Cardiovascular
1 drug is in development for Peripheral Arterial Disease.
- Companies
- 1
- Clinical trials
- 18
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Peripheral Arterial Disease pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Preclinical(1)
| Drug | Company |
|---|---|
| proflow | SCICLONE PHARMACEUTICALS INC (SCLN) |
About this indication
Peripheral Arterial Disease context
Cardiovascular·MeSH: Peripheral Arterial Disease (D058729)
Also known as: Artery Disease, Peripheral, Artery Diseases, Peripheral, Peripheral Arterial Diseases
Prevalence
1581.5 / 100K
Incidence
164.2 / 100K/yr
Frequently asked questions
How many drugs are in development for Peripheral Arterial Disease?
BioSniper tracks 1 drug in development for Peripheral Arterial Disease across 1 company.
How many clinical trials target Peripheral Arterial Disease?
There are 18 clinical trials targeting Peripheral Arterial Disease tracked by BioSniper.
What is the prevalence of Peripheral Arterial Disease?
The estimated prevalence of Peripheral Arterial Disease is approximately 1581.5 per 100,000 population.